Genetic alterations in Type 2 Diabetes: regulation of PED/PEA-15 gene expression

Teperino, Raffaele (2008) Genetic alterations in Type 2 Diabetes: regulation of PED/PEA-15 gene expression. [Tesi di dottorato] (Inedito)

Full text disponibile come:

[img]
Preview
PDF (PhD Thesis Dr. Raffaele Teperino) - Richiede un editor Pdf del tipo GSview, Xpdf o Adobe Acrobat Reader
1424Kb

Abstract

Background and Aims – PED/PEA-15 is a gene commonly overexpressed in tissues from type 2 diabetic individuals and healthy subjects at high risk of developing diabetes (such as first degree relatives). Indeed, overexpression of the PED/PEA-15 gene in mice, impairs glucose tolerance and leads to diabetes in conjunction with high-fat diet treatment. The Hepatocyte Nuclear Factor 4 (HNF4 is a liver-enriched nuclear receptor involved in the control of glucose homeostasis. Point mutations in HNF4 impair liver and pancreatic regulation of glucose homeostasis and cause Maturity Onset Diabetes of the Young Type 1 (MODY 1) More recently, genetic and biochemical evidences indicate that HNF4 may also play a role in the development of Type 2 Diabetes. Recent evidences in our lab, indicate that HNF4 inhibits PED/PEA-15 expression in liver by binding its responsive element on PED/PEA-15 promoter. The aim of this work is to understand the molecular mechanism by which HNF4 exerts its action on PED/PEA-15 expression and test the hypothesis that HNF4might induce a packaging of chromatin in the region of PED/PEA-15 promoter. Materials and Methods – Hela and HepG2 cells are used in this study. A bioinformatic analysis has been performed using the software RECON to map potential nucleosomes on the core-promoter of PED/PEA-15, and Micrococcal Nuclease (MNase) Protection Assay has been used to further confirm “in silico” data. Chromatin Immunoprecipitation (ChIP) and ReChIP Assays have been performed to identify histone marks and histone-associated proteins. Results – This work shows the fundamental role of HNF4 in directing nucleosome assembly and histone deacetylation to maintain PED/PEA-15 gene repression in HepG2 cells. This data has been further confirmed both in Hela cells overexpressing HNF4 wild-type (Hela-HNF). Both in Hela-HNF and HepG2 cells HNF4 expression promotes the assembly of histone deacetylase (HDAC), complex on the PED/PEA-15 promoter and leads to the deacetylation of histone H3 and subsequent di-methylation of its Lysine9. Furthermore, HNF4interacts with and recruits SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) corepressor to PED/PEA-15 promoter leading the associated chromatin to condense. These modifications are barely undetectable in both Hela and in HepG2 cells transfected by an HNF4 specific shRNA (Hep-sh), where HNF4 is expressed at low levels. Conclusions – These results suggest that HNF4 functions as a scaffold protein for both HDAC and HMT activities to inhibit PED/PEA-15 transcription, thus representing a new potential molecular tool to target PED/PEA-15 expression. Further in vivo studies should be done to determine whether HNF4 may act via chromatin remodelling even in vivo and whether alterations of this mechanism might play a role in the overexpression of PED/PEA-15 gene observed in type 2 diabetic patients and their healthy first degree relatives.

Tipologia di documento:Tesi di dottorato
Parole chiave:Dibetes, Phosphoprotein Enriched in Diabetes/Phosphoprotein Enriched in Astrocytes-15, Hepatocyte Nuclear Factor-4alpha, Chromatin remodelling
Settori scientifico-disciplinari MIUR:Area 06 Scienze mediche > MED/04 PATOLOGIA GENERALE
Coordinatori della Scuola di dottorato:
Coordinatore del Corso di dottoratoe-mail (se nota)
Avvedimento, Vittorio Enricoavvedim@unina.it
Tutor della Scuola di dottorato:
Tutor del Corso di dottoratoe-mail (se nota)
Beguinot, Francescobeguino@unina.it
Stato del full text:Accessibile
Data:27 Novembre 2008
Numero di pagine:74
Istituzione:Università degli Studi di Napoli "Federico II"
Dipartimento o Struttura:Biologia e Patologia Cellulare e Molecolare "L. Califano"
Tipo di tesi:Dottorato
Stato dell'Eprint:Inedito
Scuola di dottorato:Medicina Molecolare
Denominazione del dottorato:Patologia e Fisiopatologia Molecolare
Ciclo di dottorato:XXI
Numero di sistema:3472
Depositato il:18 Novembre 2009 12:35
Ultima modifica:18 Novembre 2009 12:35

Solo per gli Amministratori dell'archivio: edita il record